natgillin/translations-raw huggingface dataset:
Because of the potential for Transfusion Associated Graft Versus Host Disease (TAGVHD) it is recommended that patients who have been treated with MabCampath receive irradiated blood products.
Zaradi možnosti pojava s transfuzijo povezane bolezni presadka proti gostitelju, je priporočljivo da bolniki, ki so bili zdravljeni z zdravilom MabCampath dobijo obsevane krvne izdelke.
Because of the potential harm to the infant, mothers should be advised against breast-feeding while receiving Tarceva.
Zaradi možnega škodljivega vpliva na otroka naj doječe matere med zdravljenjem z zdravilom Tarceva ne dojijo.
Because of the potential risk of thrombotic complications with factor IX products, clinical surveillance for early signs of thrombotic and consumptive coagulopathy should be initiated with appropriate biological testing when administering this product to patients with liver disease, to patients post-operatively, to new- born infants, or to patients at risk of thrombotic phenomena or disseminated intravascular coagulation (DIC).
Zaradi morebitnega tveganja trombotičnih zapletov z zdravili, ki vsebujejo faktor IX, je potreben klinični nadzor zgodnjih znakov trombotične in porabnostne koagulopatije z ustreznim biološkim testiranjem, če to zdravilo dajemo bolnikom z boleznijo jeter, bolnikom po kirurškem posegu, novorojenčkom ali bolnikom s tveganjem trombotičnih pojavov ali diseminirane intravaskularne koagulacije (DIK).
Because of the presence of benzyl alcohol the medicinal product must not be given to premature babies or neonates.
Zaradi vsebnosti benzilalkohola se zdravilo ne sme dajati nedonošenčkom ali novorojencem.
Because of the prevalence of this allele in other Asian populations (e.g, above 15% in the Philippines and Malaysia), testing genetically at risk populations for the presence of HLA- B*1502 may be considered.
Zaradi prevalence tega alela pri drugih azijskih populacijah (npr. več kot 15 % na Filipinih in v Maleziji), se lahko razmisli o genskem testiranju prisotnosti HLA-B*1502 pri populaciji, kjer obstaja tveganje.
Because of the rarity of data on treatment with hydroxycarbamide in children less than 2 years of age, dose regimens have not been established and thus, in this population, the treatment with hydroxycarbamide is not recommended.
Zaradi redkosti podatkov o zdravljenju s hidroksikarbamidom pri otrocih, mlajših od 2 let, režima odmerjanja še niso določili, zato pri tej skupini bolnikov zdravljenje s hidroksikarbamidom ni priporočljivo.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zaradi nevarnosti alergijskih reakcij pri dajanju koncentratov faktorja IX morate na začetku faktor IX dati, glede na presojo lečečega zdravnika, pod zdravstvenim nadzorom in kjer lahko omogočite ustrezno zdravstveno oskrbo alergijskih reakcij.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zaradi tveganja alergijskih reakcij pri koncentratih faktorja IX je treba opraviti začetne aplikacije faktorja IX, če lečeči zdravnik tako presodi, pod medicinskim nadzorom, kjer je možno nuditi ustrezno medicinsko oskrbo v primeru alergijskih reakcij.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zaradi tveganja za nastanek alergijskih reakcij s koncentrati faktorja IX je treba dajanje začetnih odmerkov faktorja IX po presoji lečečega zdravnika izvajati pod zdravniškim nadzorom, kjer lahko zagotovimo ustrezno medicinsko oskrbo v primeru nastopa alergijskih reakcij.
Because of the risk of allergic reactions with factor IX products, the initial administration of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zaradi tveganja za nastanek alergijskih reakcij pri uporabi zdravil s faktorjem IX je treba začetno dajanje faktorja IX po presoji lečečega zdravnika izvajati pod zdravniškim nadzorom, kjer lahko zagotovimo ustrezno medicinsko oskrbo v primeru nastopa alergijskih reakcij.
Because of the risk of allergic reactions with factor IX products, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zaradi tveganja alergijskih reakcij z zdravili, ki vsebujejo faktor IX, je treba začetno dajanje faktorja IX v skladu z oceno lečečega zdravnika izvesti med zdravstvenim opazovanjem, pri čemer je na voljo ustrezna zdravniška oskrba za alergijske reakcije.
Because of the risk of allergic reactions with factor IX, your initial administration of IDELVION should be performed under medical observation where proper medical care for allergic reactions can be provided.
Zaradi tveganja pojava alergijskih reakcij, povezanih s faktorjem IX, mora začetno dajanje zdravila IDELVION potekati pod zdravniškim nadzorom, kjer je mogoče zagotoviti ustrezno zdravstveno oskrbo alergijskih reakcij.
Because of the risk of allergic reactions with factor IX, your initial administrations of BeneFIX should be performed under medical observation where proper medical care for allergic reactions can be provided.
Zaradi tveganja alergijskih reakcij pri faktorju IX je treba začetne aplikacije zdravila BeneFIX opraviti pod medicinskim nadzorom, kjer vam bo v primeru alergijskih reakcij možno nuditi ustrezno medicinsko oskrbo.
Because of the risk of hepatitis, serum transaminases, including ALT, should be measured before and during therapy with riluzole.
Zaradi tveganja za hepatitis je treba pred začetkom zdravljenja z riluzolom in med zdravljenjem z njim določati serumske transaminaze, vključno z ALT.
Because of the risk of high blood pressure, special care should be taken to monitor and control the patient’s blood pressure to avoid complications such as a hypertensive crisis.
Zaradi nevarnosti visokega krvnega tlaka je potrebna posebna previdnost pri spremljanju in nadzoru bolnikovega krvnega tlaka, da se preprečijo zapleti, kot je hipertenzivna kriza.
Because of the risk of infusion reactions, the patient is to be given preventive treatment consisting of an anti-inflammatory medicine, an antihistamine and paracetamol before every infusion.
Zaradi tveganja infuzijskih reakcij bo bolnik pred vsakim infundiranjem prejel preventivno zdravljenje, ki bo sestavljeno iz protivnetnega zdravila, antihistaminika in paracetamola.
Because of the risk of liver problems, the doctor will measure the levels of liver enzymes before treatment, and every month during treatment with Stayveer.
Zaradi tveganja za pojav težav z jetri mora zdravnik izmeriti ravni jetrnih encimov pred začetkom zdravljenja z zdravilom Stayveer in nato še vsak mesec med zdravljenjem.
Because of the risk of liver problems, the doctor will measure the levels of liver enzymes before treatment, and every month during treatment with Tracleer.
Zaradi tveganja težav z jetri bo zdravnik izmeril raven jetrnih encimov pred zdravljenjem in nato vsak mesec med zdravljenjem z zdravilom Tracleer.
Because of the risk of potentially fatal, acute liver injury, Tasmar should not be considered as a first- line adjunct therapy to levodopa/benserazide or levodopa/carbidopa (see sections 4.4 and 4.8).
Zaradi tveganja za nastanek potencialno življenje ogrožajoče, akutne poškodbe jeter, zdravila Tasmar ne uporabljamo za dodatno zdravljenje prve izbire pri terapiji z levodopo/benserazidom ali levodopo/karbidopo (glejte poglavje 4.4 in 4.8).
Because of the risk of rare but potentially fatal acute liver injury, Tasmar is only indicated for use in patients with levodopa-responsive idiopathic Parkinson’s disease and motor fluctuations, who failed to respond to or are intolerant of other COMT inhibitors.
Zaradi tveganja za nastanek redke, a potencialno življenje ogrožajoče akutne poškodbe jeter, je zdravilo Tasmar indicirano le pri bolnikih z na levodopo odzivno idiopatsko Parkinsonovo boleznijo in motoričnimi fluktuacijami, ki se niso odzvali na zdravljenje z ostalimi zaviralci COMT ali jih ne prenašajo.
Because of the risk of transmission of aspergillosis to people, personal protective equipment consisting of latex gloves and a mask should therefore be worn when handling infected birds or when cleaning the syringe.
Zaradi tveganja prenosa aspergiloze na ljudi je treba pri ravnanju z okuženimi pticami ali čiščenju injekcijske brizge nositi osebno zaščitno opremo, ki vključuje rokavice iz lateksa in masko.
Because of the risk of transmission of aspergillosis to people, protective personal equipment consisting of latex gloves and a mask should therefore be worn when handling infected birds or when cleaning the syringe.
Zaradi tveganja prenosa aspergiloze na ljudi je treba pri ravnanju z okuženimi pticami ali čiščenju injekcijske brizge nositi osebno zaščitno opremo, ki vključuje rokavice iz lateksa in masko.
Because of the species-specific sensitivity of dogs to develop intussusception, this finding is considered not relevant for adult humans.
Zaradi občutljivosti psov, specifične za vrsto, za razvoj invaginacije, ta izsledek ni pomemben za odrasle ljudi.
Because of the viscosity of the reconstituted medicinal product care must be taken to withdraw all of the medicinal product from the vial before expelling any air or excess solution from the syringe in order to obtain the 0.6 ml.
Zaradi viskoznosti rekonstituiranega zdravila morate paziti, da boste iz viale odstranili zdravilo v celoti, preden boste iz brizge odstranili zrak ali odvečno raztopino, da boste dobili potrebnih 0,6 ml.
Because of the viscosity of the reconstituted medicinal product care must be taken to withdraw all of the medicinal product from the vial before expelling any air or excess solution from the syringe in order to obtain the 0.6 ml.
Zaradi viskoznosti rekonstituiranega zdravila morate paziti, da boste zdravilo v celoti odstranili iz viale, preden boste iz brizge odstranili zrak ali odvečno raztopino, da boste dobili potrebnih 0,6 ml.
Because of the viscosity of the reconstituted medicinal product care must be taken to withdraw all of the medicinal product from the vial before expelling any air or excess solution from the syringe in order to obtain the 1.2 ml.
Zaradi viskoznosti rekonstituiranega zdravila morate paziti, da boste iz viale odstranili zdravilo v celoti, preden boste iz brizge odstranili zrak ali odvečno raztopino, da boste dobili potrebnih 1,2 ml.
Because of the viscosity of the reconstituted medicinal product care must be taken to withdraw all of the medicinal product from the vial before expelling any air or excess solution from the syringe in order to obtain the 1.2 ml.
Zaradi viskoznosti rekonstituiranega zdravila morate paziti, da boste zdravilo v celoti odstranili iz viale, preden boste iz brizge odstranili zrak ali odvečno raztopino, da boste dobili potrebnih 1,2 ml.
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Bondenza is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zaradi možnih dražečih učinkov ter možnega poslabšanja predhodne bolezni je treba zdravilo Bondenza pri bolnikih z aktivnimi obolenji zgornjega dela prebavil (npr. potrjenim Barrettovim požiralnikom, disfagijo, drugimi boleznimi požiralnika, gastritisom, duodenitisom ali razjedami) uporabljati previdno.
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Bonviva is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zaradi možnih dražečih učinkov ter možnega poslabšanja predhodne bolezni je treba zdravilo Bonviva pri bolnikih z aktivnimi obolenji zgornjega dela prebavil (npr. potrjenim Barrettovim požiralnikom, disfagijo, drugimi boleznimi požiralnika, gastritisom, duodenitisom ali razjedami) uporabljati previdno.
Because of this Advate has been compared with Recombinate to show that the two medicines are equivalent in one main study including 111 patients with haemophilia A.
Zdravilo Advate so zato v eni glavni študiji s 111 bolniki s hemofilijo A primerjali z zdravilom Recombinate, da bi dokazali, da sta zdravili enakovredni.
Because of this T790M mutation, medicines that block EGFR may no longer work.
Zaradi te mutacije T790M je možno, da zdravila, ki blokirajo EGFR, ne delujejo več.
Because of this, concomitant use of opicapone with MAO inhibitors (e.g. phenelzine, tranylcypromine and moclobemide) other than those for the treatment of Parkinson’s disease is contraindicated.
Zato je sočasna uporaba opikapona z zaviralci MAO (npr. fenelzin, tranilcipromin in moklobemid), razen tistimi za zdravljenje Parkinsonove bolezni, kontraindicirana.
Because of this, Helixate NexGen has been compared with Helixate to show that the two medicines are equivalent.
Zaradi tega so zdravilo Helixate NexGen primerjali z zdravilom Helixate, da bi dokazali, da sta obe zdravili enakovredni.
Because of this, Kogenate Bayer has been compared with Kogenate to show that the two medicines are equivalent.
Zaradi tega so zdravilo Kogenate Bayer primerjali z zdravilom Kogenate, da bi dokazali, da sta obe zdravili enakovredni.
Because of this, Meloxidyl’s benefit is taken as being the same as that of the reference medicinal product.
Zaradi tega velja, da so koristi zdravila Meloxidyl enake kot pri referenčnem zdravilu.
Because of this, treatment should be carried out in collaboration with a specialised centre that has experience with this type of procedure and can monitor the stem cells correctly.
Zato je treba zdravljenje izvesti v sodelovanju s specializiranim centrom, ki ima izkušnje s tovrstnimi postopki in v katerem lahko ustrezno nadzorujejo matične celice.
Because of very low BH4 levels phenylalanine is not used properly and its levels rise, resulting in harmful effects.
Zaradi nizkih ravni BH4, se fenilalanin ne more ustrezno uporabljati in se zato njegove ravni povišajo, kar ima za posledico škodljive učinke.
Because Olanzapine Apotex is a generic medicine and is bioequivalent to the reference medicines, its benefit and risk are taken as being the same as the reference medicines’.
Ker je zdravilo Olanzapine Apotex generično zdravilo in je biološko enakovredno referenčnima zdraviloma, so koristi in tveganja enaki kot pri referenčnima zdraviloma.
Because Olanzapine Cipla is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Ker je zdravilo Olanzapine Cipla generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Olanzapine Glenmark is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Olanzapine Glenmark generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Olazax is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Ker je zdravilo Olazax generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Olazax is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Zyprexa.
Ker je zdravilo Olazax generično zdravilo, so bile študije omejene na preskuse, s katerimi se dokazuje, da je biološko enakovredno referenčnemu zdravilu Zyprexa.
Because only 45 mg 13C-urea is provided overdose is not to be expected.
V enem odmerku je le 45 mg 13C-sečnine, zato ne pričakujemo možnosti prevelikega odmerjanja.
Because only 75 mg 13C-urea is provided overdose is not to be expected.
V enem odmerku je le 75 mg 13C-sečnine, zato ne pričakujemo možnosti prevelikega odmerjanja.
Because only a small number of adults were involved in the study, the assessment of the medicine’s benefits was based mainly on the results from the babies.
Ker je bilo v študijo vključeno le malo odraslih, temeljijo ocene koristi zdravil predvsem na rezultatih pri dojenčkih.
Because Oprymea is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Ker je zdravilo Oprymea generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Oprymea is a generic medicine, studies in people have been limited to tests to demonstrate that it is bioequivalent to the reference medicine, Sifrol.
Ker je zdravilo Oprymea generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Sifrol.
Because Paglitaz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Paglitaz generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Palonosetron Accord is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Palonosetron Accord generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Palonosetron Hospira is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Palonosetron Hospira generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because PecFent is a hybrid generic, the applicant presented data on the reference medicines in addition to results from its own studies.
Ker je zdravilo PecFent hibridno generično zdravilo, je predlagatelj poleg rezultatov svojih študij predložil tudi podatke o referenčnih zdravilih.
Because Pemetrexed Accord is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetreksed Accord generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pemetrexed Fresenius Kabi is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetreksed Fresenius Kabi generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pemetrexed Hospira is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetreksed Hospira generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pemetrexed Lilly is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetrexed Lilly generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pemetrexed medac is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetreksed medac generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pemetrexed Sandoz is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pemetrexed Sandoz generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pheburane is a hybrid medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pheburane hibridno zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pioglitazone Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pioglitazone Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pioglitazone Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pioglitazone Actavis Group generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pioglitazone Actavis is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Actos.
Ker je zdravilo Pioglitazone Actavis Group generično zdravilo, so bile študije pri bolnikih omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Actos.
Because Pioglitazone Krka is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pioglitazone Krka generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pioglitazone Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pioglitazone Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pioglitazone Teva Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pioglitazone Teva Pharma generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enake kot pri referenčnem zdravilu.
Because Potactasol is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Potactasol generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pradaxa can increase INR, the INR will better reflect VKA’s effect only after Pradaxa has been stopped for at least 2 days.
Zdravilo Pradaxa lahko poveča INR, zato bi bil učinek antagonista vitamina K z INR meritvijo merodajen šele 2 dni po ukinitvi zdravila Pradaxa.
Because Pramipexole Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pramipexole Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Accord is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Ker je zdravilo Pregabalin Accord generično zdravilo, so bile študije pri bolnikih omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Lyrica.